Publicaciones (593) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. Aligning digital CD8 + scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinoma

    Histopathology, Vol. 72, Núm. 2, pp. 270-284

  2. Assessment of metabolic patterns and new antitumoral treatment in osteosarcoma xenograft models by [ 18 F]FDG and sodium [ 18 F]fluoride PET

    BMC Cancer, Vol. 18, Núm. 1

  3. TPEN exerts antitumor efficacy in murine mammary adenocarcinoma through an H 2 O 2 signaling mechanism dependent on caspase-3

    Anti-Cancer Agents in Medicinal Chemistry, Vol. 18, Núm. 11, pp. 1617-1628

  4. A 30-s exposure to ethanol 20% is cytotoxic to human keratinocytes: possible mechanistic link between alcohol-containing mouthwashes and oral cancer

    Clinical Oral Investigations, Vol. 22, Núm. 8, pp. 2943-2946

  5. A 60-Year-Old Male Smoker With Chronic Obstructive Pulmonary Disease and Hypereosinophilia

    Archivos de Bronconeumologia, Vol. 54, Núm. 7, pp. 394-395

  6. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

    Brain, Vol. 141, Núm. 10, pp. 2895-2907

  7. A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer

    Clinical Breast Cancer, Vol. 18, Núm. 4, pp. e613-e619

  8. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

    Cell, Vol. 175, Núm. 2, pp. 313-326

  9. A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation

    EMBO Molecular Medicine, Vol. 10, Núm. 12

  10. A Technology-Enabled Solution to Manage Referrals to Hospice and Palliative Care Beds: The Ottawa SMART System as a Case Study

    Healthcare quarterly (Toronto, Ont.), Vol. 20, Núm. 4, pp. 63-67

  11. A diphenyldiselenide derivative induces autophagy via JNK in HTB-54 lung cancer cells

    Journal of Cellular and Molecular Medicine, Vol. 22, Núm. 1, pp. 289-301

  12. A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

    Nature Communications, Vol. 9, Núm. 1

  13. A lncRNA GUARDINg genome integrity

    Nature Cell Biology, Vol. 20, Núm. 4, pp. 371-372

  14. A multicentre, randomized controlled trial of telehealth for the management of COPD

    Respiratory Medicine, Vol. 144, pp. 74-81

  15. A new approach to treat joint injuries: Combination of intra-articular and intraosseous injections of platelet rich plasma

    Platelet Rich Plasma in Orthopaedics and Sports Medicine (Springer International Publishing), pp. 145-161

  16. A new model of exercise referral scheme in primary care: Is the effect on adherence to physical activity sustainable in the long term? A 15-month randomised controlled trial

    BMJ Open, Vol. 8, Núm. 3

  17. A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients

    Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432

  18. A phase I/II dose-escalation study investigating all-oral ixazomib-melphalanprednisone induction followed by single-agent ixazomib maintenance in transplant-ineligible newly diagnosed multiple myeloma

    Haematologica, Vol. 103, Núm. 9, pp. 1518-1526

  19. A phase ii multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy

    Haematologica, Vol. 103, Núm. 8, pp. 1351-1358

  20. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Oncogene, Vol. 37, Núm. 27, pp. 3740-3752